AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Multicentric Study on Infections of the Urinary Tract After Stent Removal (MINUS-trial).

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Ghent
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The MINUS-trial is a multicentric prospective observational study in which consecutive patients, 18 years of age and older who receive a ureteral stent during any endoscopic procedure will be approached to participate. Their stent will be removed in outpatient office or by string extraction at home with or without antibiotic prophylaxis (depending on the standard of care of the participating center). A urine sample will be taken before stent removal and patients will be asked to complete a questionnaire to assess symptoms of urinary tract infection (UTI) after stent removal. If the patient experiences symptoms of UTI (urgency, frequency, dysuria or haematuria) that exceed the usually experienced post-cystoscopy symptoms, they have to provide a urine sample. The purpose of this study is to provide multi-institutional, multinational, observational data on the incidence of UTI after stent

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patient aged 18 years or above * Stent placed during endoscopic procedure * A negative urine culture (UC) pre-operatively with a single dose of antibiotic prophylaxis peri-operatively * Stent removal is planned in outpatient setting of by the patient by using a string. * Able and willing to provide consent Exclusion Criteria: * Permanent indwelling catheter (transurethral catheter, suprapubic catheter, nephrostomy tubes) * Pregnant patients * Patient performing clean intermittent (self-)catheterization * Recent history (\<3 months) of demonstrated UTI
๐Ÿ’Š

What it tests

  • Double-J stent removal
๐Ÿ“

Where

1 site
University Hospital Ghent
Ghent, Belgium
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy